Sitemap
Meet Us
- JP Morgan - San Francisco, January 9 - 12th 2012
- Journée Scientifique de la Nanomédecine - Paris, November 25th 2011
- BioEurope - Duesseldorf, October 31st-November 2nd 2011
- ASTRO - Miami, October 2-6th 2011
- ESMO / ECCO / ESTRO - Stockholm, September 23-27th 2011
- Cancer Nanotechnology Gordon Research Conference - Waterville, July 17-22 2011
- BIO 2011 - Washington, June 27-30th 2011
- ASCO 2011 - Chicago, June 03–07th 2011
- BioEquity - Paris, May 23-24th 2011
- CLINAM 2011 - Basel, May 23-25th 2011
- ESTRO International Oncology Forum - London, May 8-12 2011
- AACR - Orlando, April 2-6th 2011
- ESTRO Prevent - Bruxelles, March 20-21st 2011
- JP Morgan - San Francisco, January 10 - 13th 2011
- Technion - Paris, December 14th 2010
- EORTC-NCI-AACR symposium - Berlin, November 16-19th 2010
- Bio Malaysia 2010 - Kuala Lumpur, November 1-3rd 2010
- NanoXray Presentation - San Diego, October 31st 2010
- ASTRO - San Diego, October 31st-November 3rd 2010
- ETP Nanomed General Assembly & Forum - Milan, October 14-15th 2010
Release
- Nanobiotix Starts Clinical Trial with Lead Product NBTXR3
- Nanobiotix announces changes to its Non Executive Board
- Nanobiotix welcomes Dr Bernd Mühlenweg as Head of Business Development
- Launch of the NanomedTV
- Nanobiotix welcomes Laurent Condomine on board
- Leading nanomedicine firm Nanobiotix successfully closes its $ 11 million series-C financing round
- Nanobiotix reports ‘proof of concept’ for its nanoparticles in treating glioblastoma multiforme (brain cancer)
- Nanobiotix enters into collaboration with “SonoDrugs” consortium
- Nanobiotix announces issue of European patent protecting its nanoXray anticancer platform
- Nanobiotix and BiotechCorp announce initial focus of their collaboration
- Nanobiotix CEO Dr. Laurent Lévy is elected co-president of the French Technology Platform on Nanomedicine (FTPN)
- Nanomedicine company Nanobiotix elects former Sanofi-Aventis oncology researcher Elsa Borghi, MD, as its medical director
- Nanomedicine company Nanobiotix elects former Aventis vice chairman and CFO Patrick Langlois as its chairman